SEARCH

SEARCH BY CITATION

References

  • 1
    Gimes DA, Schuliz KF, Cates WJ. Prevention of uterine perforation during curettage abortion. JAMA 1984; 251: 21082111.
  • 2
    Schutz KF, Grimes DA, Cabes WJ. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983; i: 11821184.
  • 3
    Hakim-Elahi Tovell HM, Burnhill MS. Complications of first-trimester abortion: A report of 170 000 cases. Obstet Gynecol 1990; 76: 129135.
  • 4
    El-Refaey H, Calder L, Wheatley DN, Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet 1994; 343: 12071209.
  • 5
    Saxena P, Salhan S, Sarda N. Role of sublingual misoprostol for cervical ripening prior to vacuum aspiration in first trimester interruption of pregnancy. Contraception 2003; 67: 213217.
  • 6
    Saxena P, Salhan S, Sarda N. Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priminging in first trimester abortions. Hum Reprod 2004; 19: 14.
  • 7
    Saxena P, Salhan S, Sarda N. Sublingual versus vaginal route of misoprostol for cervical ripening prior to surgical termination of first trimester abortions. Eur J Obstet Gynecol Reprod Biol 2006; 125: 109113.
  • 8
    Ngi SW. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women, in the sixth to twelfth week of gestation. Contraception 1995; 51: 347350.
  • 9
    Lawrie A, Penney G, Templeton A. A randomized comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 1996; 103: 11171119.
  • 10
    Singh K, Fong YF, Prasad RN, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynaecol 1998; 92: 795798.
  • 11
    Singh K, Fong YF, Prasad RN, Dong F. Vaginal misoprostol for preabortion cervical priming: Is there anoptimal evacuation time interval? Br J Obstet Gynaecol 1999; 106: 266269.
  • 12
    Vimala N, Mittal S, Kumar S. Sublingual misoprostol for preabortion cervical ripening in first-trimester pregnancy termination. Contraception 2003; 67: 295297.
  • 13
    Aronsson A, Helstrom L, Gamzell-Danielsson K. Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: A randomized comparision. Contraception 2004; 69: 165169.
  • 14
    Hamoda H, Ashok PW, Flett GM, Templeton A. randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical ripening before first trimester abortion. Am J Obstet Gynecol 2004; 190: 5559.
  • 15
    Stubblefield PG. Control of pain for women undergoing abortion. Int J Obstet Gynecol 1998; 3: 131140.
  • 16
    Acute Pain Management Guideline Panel. Pain Control After Surgery: A Patient's Guide. AHCPR Pub. No. 92-0021. Rockville, MD: Agency for Health Care Policy and Research Public Health Service, US Department of Health and Human, February 1992.
  • 17
    Ngai SW, Chan YM, Tang OS, Ho PC. The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: A randomized trial. Hum Reprod 1999; 14: 21392142.
  • 18
    Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception 2001; 64: 315317.
  • 19
    Lee SW, Ho PC, Schweer H, Seyberth HW. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002; 17: 332336.
  • 20
    Tang OS, Mok KH, Ho PC. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester. Hum Reprod 2004; 19: 11011104.
  • 21
    Okanlomo KA, Ngotho D. Effect of misoprostol for cervical ripening prior to pregnancy interruption before twelve weeks of gestation. East Afr Med J 1999; 76: 552555.